BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and ...
Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com "Clinicians are under increasing pressure to do more with less," said Dr. Brian Caveney, Labcorp's ...
Clinical lab and life science services company LabCorp has signaled its latest consumer-focused shift with the announcement of a self-administered wellness test and online results portal. Called Pixel ...
Innovative GFAP blood biomarker test expands Labcorp's (LH) portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Labcorp will begin testing for monkeypox using the CDC's ...
BURLINGTON – North Carolina-based Labcorp is responding to the growing number of monkeypox cases by launching a test to detect the virus. It’s the first national lab to do so, says Labcorp, in an ...
Labcorp will begin testing for monkeypox by using the CDC’s orthopoxvirus test and is the first national laboratory to offer this PCR test. The testing will be done at Labcorp’s largest laboratory in ...
Laboratory Corporation of America Holdings or LabCorp LH recently received a new Emergency Use Authorization (EUA) from the FDA for its new COVID-19 test that uses heat extraction process instead ...
Labcorp’s first quarter was marked by continued growth in both its Diagnostics and Biopharma Laboratory Services businesses, ...